The need to recognize infants that are at high risk for developing significant jaundice is apparent in the era of routine early discharge. The aim of the present study was to prospectively determine the ability to predict severe hyperbilirubinemia in term healthy newborns (defined as total serum bilirubin of Ͼ10.0 mg/dl at day 2, Ͼ14.0 mg/dl at day 3, and Ͼ17.0 mg/dl at days 4 and 5 of life).
Neonatal jaundice commonly develops 24 to 36 hours after delivery. As an increasing number of newborns are discharged within 24 hours of birth, it is not surprising that hyperbilirubinemia requiring phototherapy is currently one of the most commonly reported indications for readmission. [1] [2] [3] [4] The danger of failing to recognize and treat neonatal jaundice following early postpartum discharge has been confirmed by reports of kernicterus in fullterm healthy newborns with no apparent hemolysis, no jaundice in the first 24 hours, and no cause (other than breastfeeding) for hyperbilirubinemia. 5 Therefore, there is a need to identify infants who are at risk for developing significant hyperbilirubinemia as early as possible. Maisels 6 has noted that, currently, the best way to focus the follow-up toward infants at greater risk of developing neonatal jaundice is to evaluate the individual characteristics of each infant on discharge from the hospital. Bhutani et al. 7 suggested that determining total serum bilirubin (TSB) on day 1 of life could greatly simplify the recognition of infants at risk. They observed that a TSB of Ͼ5 mg/dl on the first day of life identified practically all healthy term infants at risk of developing jaundice. This observation could have apparent medical and economic advantages if prospectively validated in other populations.
The aim of the present study was to prospectively determine the ability to predict severe hyperbilirubinemia in term healthy newborns based on prenatal and intranatal characteristics, as well as early TSB measurements.
METHODS
The study population included 1177 healthy fullterm (Ն37 weeks' gestation as determined by the Dubowitz method) infants born from October 29 through December 31, 1995 at Bikur-Cholim and Misgav-Original Article
Ladach university-affiliated community hospitals in Jerusalem. Infants with either ABO or Rh incompatibility and a positive direct Coomb's test or glucose-6-phosphate dehydrogenase deficiency (determined for all infants of Iraqi, Iranian, Syrian, and Kurdistan origin) were excluded from the study.
We prospectively recorded the perinatal characteristics of each newborn, including maternal blood type, age, educational attainment (years of schooling), ethnic origin, smoking, hypertension, diabetes mellitus, and breastfeeding; intranatal administration of oxytocin; meperidine; anesthesia; premature rupture of the membranes; parity; newborn sex; birth weight; gestational age; presentation; Apgar scores; blood type; hematocrit; presence of cephalohematoma; and history of jaundice in other siblings.
TSB was prospectively obtained within the first 8 to 24 hours of life, and repeated daily for the next 4 days. After discharge, parents were instructed that if their baby appeared jaundiced, they should return for a follow-up visit in the hospital outpatient department. This visit was covered by the hospital. TSB was measured using a Unitstat Bilirubinometer (Cambridge Instruments, Buffalo, NY) by determining absorbency at 460 nm with correction for hemoglobin contamination (550 nm). Hyperbilirubinemia was defined as TSB of Ͼ10.0 mg/dl at day 2, Ͼ14.0 mg/dl at day 3, and Ͼ17.0 mg/dl at days 4 to 5. To assure wide safety margins to the prediction model, we chose a more stringent definition than the one used by the American Academy of Pediatrics. 8 Informed consent was obtained from all parents of infants enrolled in the study.
Odd ratios with 95% confidence limits were calculated using a multiple logistic regression analysis of SAS Institute software (SAS Institute Inc., Cary, NC) to control for the effects of the studied independent variables. The maternal and neonatal characteristics detailed above were included in the regression model. The predictive value (for identifying newborns that subsequently develop neonatal jaundice) was determined based on the variables found to have a significant independent effect in the multiple regression models.
RESULTS
Of the 1177 infants enrolled in this study, 60 (5.1%) developed neonatal jaundice. Of these newborns, 47% were male. The distribution of the maternal and neonatal categorical characteristics and the incidence of hyperbilirubinemia according to each variable and the infants' sex are presented in Table 1 . The mean Ϯ SD of the continuous maternal and neonatal variables are described, according to whether neonatal jaundice developed, in Table 2 .
The odds ratios and 95% confidence intervals for the variables significantly associated with neonatal jaundice, as calculated in the logistic regression analysis, are shown in Table 3. A predictive model based on the factors found to have an independent significant association with jaundice is presented in Table 4 .
The predictive values without day 1 TSB determinations, and based only on day 1 TSB are also given in Table 4 . 
DISCUSSION
The prevailing trend in the United States toward early discharge is not likely to be reversed in the near future, despite recent legislative action dictating a minimal postpartum hospital stay. 9 Thus, health care providers must reestablish the way they follow newborns. We took advantage of the situation in Israel, where infants still remain in the hospital for 3 days after vaginal delivery and are all provided with free and highly accessible postnatal care. Our data show that hyperbilirubinemia is uncommon among healthy term newborns. Thus, these data further emphasize the need to predict which infants are at high risk for jaundice so that health care resources can be used more effectively. Assessing individual maternal and neonatal characteristics on discharge, to determine the individual risk for neonatal jaundice, has been advocated. 6 Our findings suggest that a model based on several variables may offer sensitivity and specificity of Ͼ80%, with low false negative rate of only 1.1%. This certainly confirms the benefit of such an assessment. However, specific risk factors may have to be evaluated for each population, and may even have to be updated from time to time. Factors such as male sex, ethnic origin, and breastfeeding may interact differently with neonatal jaundice in varying populations, and even in the same population over time. 6, 10 Furthermore, when assessing the relationship between various characteristics and neonatal hyperbilirubinemia, one must consider the definition used for jaundice. In addition, the influence of a factor such as breastfeeding may greatly vary according to its frequency and according to whether milk supplements were used.
We tried to augment the accuracy of our individual risk assessment predictive model with the use of day 1 TSB measurements. These measurements were taken according to the suggestion of Bhutani et al. 7 Examining retrospective data, they observed that none of 1140 newborns who had TSB levels of Ͻ5 mg/dl on the first day of life subsequently developed serum TSB concentrations of Ն17 mg/dl. They suggested that measurement of TSB on the first day of life could reduce the need for further bilirubin sampling and home visits. In the present prospective study, a TSB concentration of Յ5 mg/dl at an age of Յ24 hours did not completely exclude future development of jaundice, which did occur in 11 newborns (1.1%). However, a TSB concentration of Ͼ5 mg/dl at 24 hours was associated with an odds ratio of 36.5 for subsequently developing hyperbilirubinemia. Day 1 TSB levels provided sensitivity and specificity levels of 57.9% and 90.4%, respectively, similar to the values obtained using a wide array of perinatal characteristics in the predictive model. Furthermore, adding the day 1 TSB values to a prediction model based on perinatal characteristics greatly improved the sensitivity, from 57.9% to 81.8%, and reduced the false negative rate by more than half.
The cost-effectiveness of measuring day 1 serum bilirubin to improve our ability to identify infants at risk will probably depend on the local conditions at various institutes. However, in the present study, blood samples were obtained over a wide time span during the first day of life. Measuring serum bilirubin concentrations exactly 24 hours after delivery or at a later time just before discharge may improve the sensitivity of this predictor for hyperbilirubinemia. However, the significant diurnal variation in serum bilirubin levels will then have to be taken into consideration.
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Other means for improving our ability to recognize infants at risk of developing severe jaundice may include determining the end-tidal breath carbon monoxide as a measure of the bilirubin production rate. 12 Early identification of infants at greater risk for neonatal hy- perbilirubinemia may not only facilitate our ability to offer costeffective follow-up programs but may also serve as the key for determining whether preventive measures, such as pharmacologic intervention with metalloporphyrins, should be applied. 13, 14 
